Skip to content
Clinical Trials – home
FranceBack to France

Clinical trials in Pau – page 5

98 clinical trials in Pau, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

FranceOur site in FranceEssaisCliniques.fr(opens in a new tab)
Pau at a glance
98
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

98 trials in Pau

Open in trial search

Systemic scleroderma

Not yet recruiting
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Rituximab
  • Sponsor:Assistance Publique Hopitaux De Paris
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Ceftriaxone
  • Sponsor:Assistance Publique Hopitaux De Marseille
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Fluorouracil
  • Sponsor:Fondation Franc.Cancerologie Digestive
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Association Gercor
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Carboplatin
  • Sponsor:Arcagy Gineco
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Incb099280
  • Sponsor:Incyte Corp.

Colitis ulcerative

Not yet recruiting
Investigational
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Obefazimod
  • Sponsor:Abivax

Colitis ulcerative

Not yet recruiting
Investigational
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Obefazimod
  • Sponsor:Abivax
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Merck Sharp & Dohme LLC
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Eli Lilly & Co.

Dyslipidaemia

Not recruiting
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Evolocumab
  • Sponsor:Amgen Inc.

Arteriosclerosis

Not recruiting
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Atorvastatin
  • Sponsor:Novartis Pharma AG

Other cities in France

The busiest research cities in the country

All 379 cities in France

Clinical research in Pau

What the registry says about research in the country

01 Oncology Research

Innovative trials focusing on colorectal cancer, breast cancer, and lung cancer treatments. Studies evaluating targeted therapies and immunotherapy combinations for better patient outcomes.

  • Triple-negative breast cancer immunotherapy
  • Advanced biliary tract cancer treatments
  • Melanoma combination therapies

Several trials are exploring personalized treatment approaches based on genetic markers and patient response.

02 Cardiovascular Studies

Research initiatives examining atherosclerotic cardiovascular disease and innovative approaches to hypertension management. Studies focusing on antiplatelet therapy optimization.

  • Anticoagulation management
  • Renal denervation techniques
  • Cardiovascular risk reduction

Trials are evaluating both established and novel therapeutic approaches for heart conditions.

03 Autoimmune Disorders

Clinical investigations into rheumatoid arthritis and multiple sclerosis treatments. Studies evaluating combination therapies and treatment de-escalation strategies.

  • MS therapy optimization
  • Inflammatory bowel disease treatments
  • Novel RA combination therapies

Research focuses on improving long-term outcomes while optimizing treatment protocols.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.